Al Kraus is Director of Cytosorbents Corp. Currently has a direct ownership of 142,046 shares of CTSO, which is worth approximately $133,523. The most recent transaction as insider was on Feb 06, 2023, when has been sold 12,000 shares (Common Stock) at a price of $2.65 per share, resulting in proceeds of $31,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K
0% 3M change
0% 12M change
Total Value Held $133,523

Al Kraus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2023
BUY
Exercise of conversion of derivative security
$31,800 $2.65 p/Share
12,000 Added 7.79%
142,046 Common Stock
May 06 2022
BUY
Open market or private purchase
$9,800 $1.96 p/Share
5,000 Added 3.7%
130,046 Common Stock
Aug 31 2021
SELL
Open market or private sale
$37,600 $9.4 p/Share
4,000 Reduced 3.1%
125,046 Common Stock
Aug 31 2021
BUY
Exercise of conversion of derivative security
$16,480 $4.12 p/Share
4,000 Added 3.01%
129,046 Common Stock
Nov 10 2020
SELL
Open market or private sale
$64,000 $8.0 p/Share
8,000 Reduced 6.01%
125,046 Common Stock
Nov 10 2020
BUY
Exercise of conversion of derivative security
$27,600 $3.45 p/Share
8,000 Added 5.67%
133,046 Common Stock
AK

Al Kraus

Director
Princeton, NJ

Track Institutional and Insider Activities on CTSO

Follow Cytosorbents Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTSO shares.

Notify only if

Insider Trading

Get notified when an Cytosorbents Corp insider buys or sells CTSO shares.

Notify only if

News

Receive news related to Cytosorbents Corp

Track Activities on CTSO